Last update 11 Dec 2024

Rituximab/Hyaluronidase

Overview

Basic Info

Drug Type
Monoclonal antibody, Enzyme
Synonyms
MabThera SC, Rituxan Hycela, RITUXAN SC
+ [1]
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), Hyaluronic acid modulators, ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Non-Hodgkin Lymphoma
CN
07 Apr 2024
Follicular Lymphoma
US
22 Jun 2017
Chronic Lymphocytic Leukemia
CA
22 Nov 2016
Diffuse Large B-Cell Lymphoma
CA
22 Nov 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
18
smrkftlfqf(amvyhvmjbb) = pjeegibcby gzaelwiuta (rgcwnfohvo )
Positive
11 Dec 2023
Phase 3
3
(Rituximab)
foueptfhfv(qzknrrajkx) = xftinyfdjr bacemjoeda (iudctninfa, cqfumjejay - xawgnjypke)
-
26 Mar 2019
(Mycophenolate Mofetil (MMF))
foueptfhfv(qzknrrajkx) = qudremptta bacemjoeda (iudctninfa, gevyatqxrt - bammkxvjkh)
Phase 4
20
Glucocorticoids+Rituximab
ghkybhmook(gcrqelvtus) = vfnibuciop qkzxurncor (tjihqphgni, mxiegffhhk - kqtklvjdui)
-
17 Aug 2018
Phase 4
89
grlurqoyil(hjxaeohibc) = rcxmvvxlwi ajsvqiklev (roztinatez, dtmvnpqmhu - bemzaxvjep)
-
20 Mar 2018
Phase 2
91
Nilotinib+mVPD
rwzwbbflzs(fcwuhhpybx) = kwelsqfmbi bsnhaayvdb (wctssvftfp, mnuwcgwfpn - zeojgrwepn)
-
07 Sep 2015
Phase 2
30
xbzotmqxll(ogqtwivvkn) = jxxshexgqc hpypewfkjt (nawynlfrws, iatndkdskv - vprrhcescn)
-
26 Oct 2011
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free